IPO Observation | No Product Launch from Biotech Company, Three Years of Losses Almost $10 Billion
Recently, Biotech Company has submitted its IPO application to the Hong Kong Stock Exchange again, with Goldman Sachs and Jefferies serving as joint sponsors.